ADA Scientific Sessions 2026 Abstract
Targeting Endogenous Retroviruses as a Novel Immunometabolic Therapy: HERV-K Activation in Human Tissues and Proof-of-Concept Rescue in Diabetic Mice
Experiments in miceInterventions
ERV-specific T- and B-cell responses
Papers on ERV-specific T- and B-cell responses
1 paper